ArticleFrontiers in cellular and infection microbiology2026
A multidimensional nomogram for clinical risk stratification of bloodstream infection and mortality in hematologic malignancies.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bloodstream infections (BSIs) are serious complications in patients with hematologic malignancies (HMs) and are associated with substantial morbidity and mortality. Effective risk stratification is crucial for optimizing empirical antimicrobial decisions. This study aimed to develop and internally validate nomograms for predicting BSI occurrence and post-BSI mortality among HM patients. Methods: This retrospective cohort study enrolled 3,014 HM patients, including 725 with BSI. The cohort was randomly divided into derivation and internal validation cohorts at a 6:4 ratio. The BSI occurrence model was developed using multivariable logistic regression, while the post-BSI mortality prediction model among patients with BSI was developed using Cox regression. Model performance was evaluated based on discrimination, calibration, and decision curve analysis. Results: The BSI occurrence model demonstrated acceptable discrimination, with area under the receiver operating characteristic curve (AUC) values of 0.775 in the derivation cohort and 0.761 in the internal validation cohort. The final nomogram incorporated 12 variables, among which neutrophil count ≤0.5 × 10 Conclusions: The BSI occurrence model showed acceptable discrimination in the derivation and internal validation cohorts and was preliminarily assessed in an independent cohort. The post-BSI mortality model showed moderate discrimination in the internal validation cohort and requires further evaluation in larger and more representative populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.